What do healthy bone marrow cells in children look like? For the first time, researchers have mapped this out. Scientists at the Princess Máxima Center examined nearly 91,000 individual bone marrow ...

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

Researchers mapped nearly 91,000 healthy bone marrow cells from donors aged two to 32, creating the first pediatric atlas.

New findings reveal that succinate signaling through SUCNR1 acts as a protective brake in acute myeloid leukemia. Modulating ...

The U.S. Food and Drug Administration (FDA) has approved Filkri (filgrastim-laha), a biosimilar to Neupogen (filgrastim), to ...

First and only all-oral, fixed-duration regimen designed to provide CLL patients with the potential to experience time off treatment –– Approval expands Genentech’s fixed-duration portfolio by ...

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...

Without treatment, Max Uribe faces a high risk of developing life-threatening blood cancers. His father, Juan Uribe, turned to social media for help, and his plea has now reached a global audience, ...

US FDA approves AstraZeneca’s Calquence plus venetoclax as first all-oral, fixed-duration combination for patients with CLL in the 1st-line setting: Cambridge, UK Monday, Februa ...

Tony Garcia, who survived leukemia as a child back in the 1970s and '80s when a diagnosis was practically a death sentence, has written a book about the experience. "My Childhood Cut Short — ...

By the time cancer symptoms appear, the disease has already been developing for years, often leaving subtle clues in routine bloodwork long before diagnosis.

On Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie Inc.'s ABBV combination treatment for chronic ...